Evidence mapPaperPMID 41901744Full record

ReviewPathogens (Basel, Switzerland)2026

Antimicrobial Resistance: A Bibliometric Review of Patient Health, Mechanisms, and Therapeutic Strategies.

Peter E Murray, Jonathan A Coffman, Franklin Garciá-Godoy

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peter E MurrayIndependent Researcher, San Francisco, CA 94102, USA.ORCID 0000-0001-9005-1431
Jonathan A CoffmanDepartment of Biomedical Sciences, Mercer University School of Medicine, Mercer, GA 31207, USA.
Franklin Garciá-GodoyCollege of Dentistry, University of Tennessee Health Science Center, Memphis, TN 38103, USA.ORCID 0000-0001-8133-3306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a growing global health crisis, with projections estimating up to 10 million deaths annually and more than 130 million hospitalizations attributable to resistant infections. Resistance emerges through microbial adaptation to sustained antimicrobial pressure, resulting in genetic and phenotypic mechanisms such as target mutations, enzymatic drug inactivation, efflux pump activation, biofilm formation, and metabolic adaptation that drive the emergence of multidrug-resistant pathogens and limit effective therapy. This bibliometric review analyzes the MEDLINE-indexed articles to characterize patient health and age factors, resistance mechanisms, pathogen types, and therapeutic strategies associated with antimicrobial resistance. The findings demonstrate that antimicrobial resistance is disproportionately reported among adults and chemotherapy-treated patients, with transmitted resistance emerging as the dominant driver, emerging from antibiotic misuse or overuse. Despite extensive mechanistic knowledge, treatment remains largely focused on escalation to newer antibiotics, while combination and adjunctive therapies are less commonly reported. These results analyze 308,290 studies to identify patient-related contexts, resistance mechanisms, pathogens, and therapeutic strategies.

Indexed as

Drug Resistance, MicrobialAnti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, BacterialHumansAnti-Bacterial Agentsantibacterialantibioticsfungihygieneinfectious diseasesparasitesviruses

Identifiers

PMID41901744
PMCPMC13028830

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.